Cardiac Stem Cell Therapy Shows Promise for Regenerating Heart Muscle After Attack
Small trial tests safety of injecting patients' own cardiac stem cells to regrow dead heart tissue and restore function.
20 articles
Small trial tests safety of injecting patients' own cardiac stem cells to regrow dead heart tissue and restore function.
Large trial tests umbilical cord stem cells to prevent heart failure in heart attack patients with reduced heart function.
Researchers tested whether stem cells from healthy hearts could help repair damage in heart attack patients, offering hope for cardiac regeneration.
115-patient trial tested CardioCell stem cell treatment against placebo for chronic heart failure patients with promising regenerative approach.
Clinical trial tested whether bone marrow stem cells could improve heart function beyond standard bypass surgery alone.
Researchers tested injecting cardiac stem cells directly into heart arteries after heart attacks to promote healing and regeneration.
Completed study tested regenerative cardiac therapy in 105 heart attack patients, comparing stem cell treatment to placebo controls.
Researchers tested a novel stem cell therapy using umbilical cord cells on a pericardial matrix to repair heart tissue after heart attacks.
Stanford researchers create comprehensive database showing how maternal diet, microbiome, and medications affect fetal development.
Researchers discovered specific cell markers that predict which leukemia patients will achieve lasting remission from CAR-T therapy.
Scientists discover how damaged heart cells transform into new blood vessels, potentially revolutionizing heart failure treatment.
New research reveals how age-related blood cell changes may increase pericarditis and myocarditis risk in healthy adults.
A 2025 review maps the molecular drivers of cardiac aging and evaluates drugs, CRISPR, stem cells, and lifestyle as countermeasures.
A new review examines how drugs that clear senescent cells could transform treatment of age-related cardiovascular disease.
CAR-M2 therapy successfully reversed kidney scarring in lab studies by eliminating harmful endothelial cells and promoting healing.
CRISPR gene therapy shows promise for curing genetic heart diseases like high cholesterol and amyloidosis with one-time treatments.
Revolutionary gene-editing technology CRISPR becomes available outside the US, offering new hope for treating genetic diseases worldwide.
Inefficient cellular cleanup in the heart creates inflammation that damages non-regenerative heart muscle cells.
UC San Diego scientists developed an injectable hydrogel that travels the bloodstream to reduce inflammation and regenerate damaged heart tissue.
Breakthrough study shows one epigenetic factor can transform cardiac fibroblasts into heart muscle cells, improving function after myocardial infarction.